View All Key Stats
VVUS Key Stats
Income Statement | |
Revenue (TTM) | 56.89M |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | -4.04 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | -42.52M |
Profitability | |
Gross Profit Margin (Quarterly) | 80.74% |
Profit Margin (Quarterly) | -50.99% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield (TTM) | Upgrade |
Price and Valuation | |
Market Cap | 53.04M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio (TTM) | 0.9305 |
PE Ratio (TTM) | -- |
Price to Book Value | -- |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio (Quarterly) | Upgrade |
Free Cash Flow (Quarterly) | -8.53M |
Return on Equity (TTM) | Upgrade |
View All VVUS News
VVUS News
-
WireHeadlineTime (ET)
-
Globe Newswire02/13 07:30
-
Yahoo02/05 15:02
-
Globe Newswire02/04 16:00
-
Yahoo01/15 07:55
-
SA Breaking News01/14 12:53
-
SA Breaking News01/14 11:05
-
MT Newswires01/14 09:48
-
SA Breaking News01/14 08:03
-
Globe Newswire01/14 07:30
-
Yahoo01/03 15:29
View All Events
VVUS Events
Date | Type | Description |
---|---|---|
06/05/2019 | Misc | VIVUS Inc Annual General Meeting in 2018 |
05/08/2019 16:30 EDT | Misc | VIVUS Inc First Quarter Earnings Conference Call in 2019 |
05/08/2019 | Earnings | VIVUS Inc First Quarter Earnings in 2019 Release |
02/26/2019 16:30 EST | Misc | VIVUS Inc Fourth Quarter Earnings Conference Call in 2018 |
02/26/2019 | Earnings | VIVUS Inc Fourth Quarter Earnings in 2018 Release |
11/01/2018 16:30 EDT | Misc | VIVUS Inc Third Quarter Earnings Conference Call in 2018 |
11/01/2018 | Earnings | VIVUS Inc Third Quarter Earnings in 2018 Release |
09/11/2018 | Splits | Ratio: 1:10 |
09/07/2018 | Misc | VIVUS Inc Annual General Meeting in 2017 |
08/07/2018 16:30 EDT | Misc | VIVUS Inc Second Quarter Earnings Conference Call in 2018 |
VVUS Fundamentals
Income Statement View Statement
VVUS Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
VVUS One Page Reports
- One Page Report Download
VVUS Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 4.98 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.vivus.com
- Investor Relations URL: http://ir.vivus.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Feb. 26, 2019
- Last Earnings Release: Nov. 01, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: VIVUS Inc is a US-based biopharmaceutical company which is engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. The company's commercial products include Qsymia is an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index and Stendra/Spedra, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. The company operates through the single segment of business being Development and commercialization of novel therapeutic products.
VVUS Excel Add-In Codes
- Name: =YCI("VVUS","name")
- Description: =YCI("VVUS","description")
- Sector: =YCI("VVUS","sector")
- Industry: =YCI("VVUS","industry")
- Est. Current Fiscal Year End: =YCI("VVUS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VVUS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VVUS Tweets Stocktwits
Advertisement